Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

366
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
366
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

889
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
889
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

294
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
294
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

4.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.4K
Hormones of the Pituitary Gland01:27

Hormones of the Pituitary Gland

7.3K
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
7.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.1K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

European journal of medicinal chemistry·2011
Same author

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

The Journal of cell biology·2010
Same author

Buffalo hepcidin: characterization of cDNA and study of antimicrobial property.

Veterinary research communications·2010
Same author

High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome.

Journal of hepatology·2010
Same author

Gα13 and Rho mediate endosomal trafficking of CXCR4 into Rab11+ vesicles upon stromal cell-derived factor-1 stimulation.

Journal of immunology (Baltimore, Md. : 1950)·2010
Same author

Dlk1 is necessary for proper skeletal muscle development and regeneration.

PloS one·2010

Related Experiment Video

Updated: Oct 4, 2025

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

16.7K

Counseling for Growth Hormone Therapy.

Sanjay Kalra1, Sameer Aggarwal2, Ashok Kumar3

  • 1Consultant Endocrinologist, BRIDE Hospital, Karnal, Haryana, India.

Turkish Archives of Pediatrics
|February 3, 2022
PubMed
Summary

Growth hormone (GH) therapy improves short stature treatment. Better patient communication and counseling are crucial for adherence to recombinant human growth hormone (rHGH) therapy, ensuring optimal clinical outcomes.

More Related Videos

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

548
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

962

Related Experiment Videos

Last Updated: Oct 4, 2025

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

16.7K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

548
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

962

Area of Science:

  • Pediatrics
  • Endocrinology
  • Pharmacology

Background:

  • Growth hormone (GH) therapy is essential for treating short stature.
  • Recombinant human growth hormone (rHGH) availability has increased clinical data on GH applications.
  • Approved uses for GH extend beyond growth hormone deficiency (GHD), yet adherence remains a challenge.

Purpose of the Study:

  • To review strategies for enhancing patient communication and counseling.
  • To improve adherence to growth hormone therapy.
  • To achieve optimal clinical outcomes in patients receiving GH treatment.

Main Methods:

  • Literature review on growth hormone therapy and patient adherence.
  • Analysis of communication and counseling techniques in chronic disease management.
  • Synthesis of data on approved GH indications and treatment outcomes.

Main Results:

  • The scope of GH therapy has expanded significantly beyond GHD.
  • Poor adherence to GH therapy mirrors challenges seen in other chronic conditions.
  • Effective communication and counseling are identified as key factors for improving adherence.

Conclusions:

  • Enhanced patient-provider communication is vital for successful GH therapy.
  • Targeted counseling strategies can improve adherence rates in patients with short stature.
  • Optimizing adherence through better communication is essential for maximizing the benefits of GH treatment.